CIK 0001557746 · Non-accelerated filer<br>Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460571712
- Phone
- 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-01 | Walker Neal Director | Option exercise | +24,000 | 1,314,188 | ||
| 2023-03-01 | Walker Neal Director | Option exercise · Restricted Stock Units | −96,150 | 0 | ||
| 2023-03-01 | Walker Neal Director | Option exercise · Restricted Stock Units | −18,275 | 36,550 | ||
| 2023-03-01 | Walker Neal Director | Option exercise · Restricted Stock Units | −24,000 | 72,000 | ||
| 2023-03-01 | Monahan Joseph Chief Scientific Officer | Option exercise | +13,750 | 105,136 | ||
| 2023-03-01 | Monahan Joseph Chief Scientific Officer | Option exercise | +50,000 | 155,136 | ||
| 2023-03-01 | Monahan Joseph Chief Scientific Officer | Option exercise | +10,925 | 166,061 | ||
| 2023-03-01 | Monahan Joseph Chief Scientific Officer | Option exercise · Restricted Stock Units | −13,750 | 0 | ||
| 2023-03-01 | Monahan Joseph Chief Scientific Officer | Option exercise · Restricted Stock Units | −50,000 | 100,000 | ||
| 2023-03-01 | Monahan Joseph Chief Scientific Officer | Option exercise · Restricted Stock Units | −10,925 | 32,775 | ||
| 2023-03-01 | Balthaser Kevin Chief Financial Officer | Option exercise | +1,475 | 2,175 | ||
| 2023-03-01 | Balthaser Kevin Chief Financial Officer | Option exercise | +1,100 | 3,275 | ||
| 2023-03-01 | Balthaser Kevin Chief Financial Officer | Option exercise | +2,375 | 5,650 | ||
| 2023-03-01 | Balthaser Kevin Chief Financial Officer | Option exercise · Restricted Stock Units | −1,475 | 0 | ||
| 2023-03-01 | Balthaser Kevin Chief Financial Officer | Option exercise · Restricted Stock Units | −1,100 | 2,200 | ||
| 2023-03-01 | Balthaser Kevin Chief Financial Officer | Option exercise · Restricted Stock Units | −2,375 | 7,125 | ||
| 2023-02-15 | Monahan Joseph Chief Scientific Officer | Sale | −5,000 | $13.06 | $65K | 91,386 |
| 2023-02-08 | Loerop James Chief Business Officer | Sale | −4,267 | $13.89 | $59K | 6,983 |
| 2023-02-02 | Walker Neal Director | Sale | −1,079 | $14.57 | $16K | 1,179,684 |
| 2023-02-02 | Walker Neal Director | Sale | −600 | $15.55 | $9K | 1,179,084 |
Page 21 of 34 · 680 trades